Grants per year
Grants
Search results
-
Active
-
Analysis of Apoaequorin as a Therapeutic Agent for Schizoprenia, Depression, and Cognitive Decline
8/7/20 → 8/6/21
Project: Research project
-
Prot #IS00011961: The Mechanism Of ST100021 On Neurotransmitter Efflux Related To Psychosis
Dainippon Sumitomo Pharma Co., Ltd.
5/19/20 → 5/18/21
Project: Research project
-
Prot #SCZD-0001: A Pilot Study of Digital Health Technology Assessments in Schizophrenia
PRA Health Sciences, Millennium Pharmaceuticals, Inc
2/13/19 → 2/13/22
Project: Research project
-
Prot #SNR-05: An Adaptive, Phase II/III, Double-Blind, Randomized, Placebo-Controlled, Two-Part, Dose-Finding, Multi-Center Study of the Safety and Efficacy of NaBen® (Sodium Benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on Therapy with Clozapine
Meltzer, H. Y. & Meriden, Z.
Amarex Clinical Research, SyneuRx International (Taiwan) Corp.
3/14/18 → 3/14/21
Project: Research project
-
Prot #ACP-103-035: A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
Meltzer, H. Y., Meriden, Z. & Rado, J. T.
Quintiles, Inc., ACADIA Pharmaceuticals Inc.
9/12/17 → 6/28/21
Project: Research project
-
LiveWell: A Mobile Intervention for Bipolar Disorder
Dopke, C. A., Dopke, C. A., Goulding, E. H., Kording, K. P., Kording, K. P., Kwasny, M. J., Kwasny, M. J., Liu, L., Liu, L., Meltzer, H. Y., Meltzer, H. Y., Mohr, D. C. & Mohr, D. C.
National Institute of Mental Health
7/15/16 → 6/30/21
Project: Research project
-
Age-Related Histone Modification Effect on Antipsychotic Action
Chan, S., Csernansky, J. G., Dong, H., Fang, D. & Meltzer, H. Y.
National Institute of Mental Health
5/26/16 → 2/28/22
Project: Research project
-
Finished
-
Studies to Investigate the Mechanism of Action of Sunovion Compound SEP-856
4/26/18 → 4/26/19
Project: Research project
-
Development of transdiagnostic genetic markers to predict suicide attempt
Li, J. & Meltzer, H. Y.
American Foundation for Suicide Prevention
11/1/17 → 10/31/19
Project: Research project
-
Prot #BIO-17-1142: Contribution of dopamine D3 receptor partial agonism of cariprazine to improve cognition and psychosis
4/15/17 → 4/15/18
Project: Research project
-
Validation of a pharmacogenomic panel predicting improvement in psychopathology to atypical antipsychotic drugs
Li, J. & Meltzer, H. Y.
11/10/16 → 11/10/17
Project: Research project
-
Rapastinel Mechanism of Action and Effects on Cognitive Function
9/1/16 → 11/22/19
Project: Research project
-
Improving Outcomes in Schizophrenia Through Identification of Genetic Risk Factors
Li, J. & Meltzer, H. Y.
Clinical Reference Laboratory, Inc.
3/23/16 → 3/23/17
Project: Research project
-
Vortioxetine as a Potential Enhancer of Cognition in Schizophrenia
Takeda Pharmaceuticals U.S.A., Inc.
3/17/16 → 3/17/18
Project: Research project
-
Prot #1289.6: A phase II randomised, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of four orally administrated doses of BI 409306 during a 12-week treatment period in patients with schizophrenia on stable ant
DrugDev Inc., Boehringer Ingelheim Pharmaceuticals, Inc.
1/29/15 → 1/29/18
Project: Research project